AR065477A1 - Diaminopirimidinas - Google Patents
DiaminopirimidinasInfo
- Publication number
- AR065477A1 AR065477A1 ARP080100785A ARP080100785A AR065477A1 AR 065477 A1 AR065477 A1 AR 065477A1 AR P080100785 A ARP080100785 A AR P080100785A AR P080100785 A ARP080100785 A AR P080100785A AR 065477 A1 AR065477 A1 AR 065477A1
- Authority
- AR
- Argentina
- Prior art keywords
- halo
- alkoxy
- diaminopirimidins
- disorder
- aminosulfonyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Compuestos de la formula (1) o una sal farmacéuticamente aceptable del mismo. R1 es alcoxi C1-6, hidroxi o halo; y R2 es alcoxi C1-6, halo, alquilo C1-6; alquilsulfonilo C1-6 o aminosulfonilo. Composicion farmacéutica, método para obtener (1) y parapreparar medicamento para enfermedad del tracto urinario, un estado patologico doloroso, un trastorno respiratorio o trastorno gastrointestinal.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90407907P | 2007-02-28 | 2007-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR065477A1 true AR065477A1 (es) | 2009-06-10 |
Family
ID=39297415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080100785A AR065477A1 (es) | 2007-02-28 | 2008-02-26 | Diaminopirimidinas |
Country Status (6)
Country | Link |
---|---|
US (1) | US20080207655A1 (es) |
AR (1) | AR065477A1 (es) |
CL (1) | CL2008000554A1 (es) |
PE (1) | PE20090624A1 (es) |
TW (1) | TW200845995A (es) |
WO (1) | WO2008104474A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007304280B2 (en) * | 2006-10-04 | 2013-01-31 | F. Hoffmann-La Roche Ag | Process for synthesis of phenoxy diaminopyrimidine derivatives |
US8785694B2 (en) | 2012-06-05 | 2014-07-22 | Connora Technologies, Inc | Processes for the preparation of di-(2-aminoethyl) formal, di-(3-aminopropyl) formal, and related molecules |
WO2015027212A1 (en) * | 2013-08-23 | 2015-02-26 | Afferent Pharmaceuticals Inc. | Diaminopyrimidine p2x3 and p2x 2/3 receptor modulators for treatment of acute, sub-acute or chronic cough |
PT3355889T (pt) * | 2015-09-29 | 2023-04-26 | Afferent Pharmaceuticals Inc | Moduladores de recetores de diaminopirimidina p2x3 e p2x2/3 para utilização no tratamento da tosse |
CA3016773A1 (en) | 2016-03-14 | 2017-09-21 | Ronald Charles Hawley | Pyrimidines and variants thereof, and uses therefor |
MA44489A (fr) | 2016-03-25 | 2019-01-30 | Afferent Pharmaceuticals Inc | Pyrimidines et variants de celles-ci, et leurs utilisations |
WO2018118668A1 (en) | 2016-12-20 | 2018-06-28 | Afferent Pharmaceuticals, Inc. | Crystalline salts and polymorphs of a p2x3 antagonist |
US10919839B2 (en) | 2017-07-11 | 2021-02-16 | Aditya Birla Chemicals (Usa) Llc | Silicon-containing compositions and their methods of use |
US20220249478A1 (en) * | 2019-04-30 | 2022-08-11 | Beijing Tide Pharmaceutical Co., Ltd. | Method for treating endometriosis-associated pain by using diaminopyrimidine compound |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1725540E (pt) * | 2004-03-05 | 2012-11-29 | Hoffmann La Roche | Diaminopirimidinas como antagonistas de p2x3 e p2x2/3 |
KR101012926B1 (ko) * | 2005-09-01 | 2011-02-09 | 에프. 호프만-라 로슈 아게 | P2x3 및 p2x2/3 조정자로서의 다이아미노피리미딘 |
JP4850913B2 (ja) * | 2005-09-01 | 2012-01-11 | エフ.ホフマン−ラ ロシュ アーゲー | P2x3及びp2x2/3調節因子としてのジアミノピリジン |
WO2007025899A1 (en) * | 2005-09-01 | 2007-03-08 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
-
2008
- 2008-02-18 WO PCT/EP2008/051944 patent/WO2008104474A1/en active Application Filing
- 2008-02-25 CL CL200800554A patent/CL2008000554A1/es unknown
- 2008-02-25 PE PE2008000379A patent/PE20090624A1/es not_active Application Discontinuation
- 2008-02-25 TW TW097106480A patent/TW200845995A/zh unknown
- 2008-02-26 AR ARP080100785A patent/AR065477A1/es unknown
- 2008-02-27 US US12/072,664 patent/US20080207655A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CL2008000554A1 (es) | 2008-08-29 |
WO2008104474A1 (en) | 2008-09-04 |
PE20090624A1 (es) | 2009-05-16 |
US20080207655A1 (en) | 2008-08-28 |
TW200845995A (en) | 2008-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR065477A1 (es) | Diaminopirimidinas | |
RU2435759C2 (ru) | Производные бензимидазолов и их применение для модуляции гамка-рецепторного комплекса | |
ES2611483T3 (es) | Agente terapéutico para enfermedad inflamatoria intestinal | |
EA201000609A1 (ru) | Замещенные пиперидинодигидротиенопиримидины | |
DE502005010170D1 (de) | Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel | |
EA200702200A1 (ru) | Дигидротиенопиримидины для лечения воспалительных заболеваний | |
CL2008003326A1 (es) | Compuestos derivados de [(2r)-3-[2-(5-fluoro-4-pirimidinil)hidrazino]-3-oxopropil]hidroxiformamida, formas polimorficas 1, 2 y 3 de dichos compuestos; composicion farmaceutica; y su uso en el tratamiento de una enfermedad bacteriana del oido, sinusitis, infeccion del tracto respiratorio superior, entre otras. | |
CL2021000491A1 (es) | Combinaciones para tratamiento de ehna/ehgna y enfermedades relacionadas | |
MX337396B (es) | Metodo para el tratamiento de enfermedades del riñon poliquisticas con derivados de ceramica. | |
JP2008500378A5 (es) | ||
CY1112429T1 (el) | Υποκατεστημενα παραγωγα σουλφοναμιδιου | |
MX2007011009A (es) | Compuestos de piperidina 3,4,5-substituidos. | |
EA200870302A1 (ru) | 1,3-диоксанкарбоновые кислоты | |
ATE524450T1 (de) | 5-phenyl-isoxazol-3-carboxamid-derivate als trpv1-modulatoren | |
CA2777746A1 (en) | Benzoimidazole compounds and uses thereof | |
BRPI0514735B8 (pt) | derivados de pirimidino sulfonamida como moduladores do receptor de quimiocina. | |
EA201400521A1 (ru) | Гетероциклические соединения, лекарственные средства, содержащие указанные соединения, их применение и способы их получения | |
GEP20166483B (en) | Phenyl-3-aza-bicyclo[3.1.0] hex-3-yl-methanones and the use thereof as medicament | |
EA200701615A1 (ru) | Новые лекарственные средства для лечения заболеваний дыхательных путей | |
RU2012137245A (ru) | Индуктор считывания и терапевтический агент для генетических заболеваний, вызванных мутациями типа нонсенс-мутаций | |
EA201270653A1 (ru) | Антагонист dpи его применение | |
EA200900269A1 (ru) | Лекарственные комбинации для лечения заболеваний дыхательных путей | |
JP2013523739A5 (es) | ||
ECSP099082A (es) | Beta-agonistas enantioméricamente puros, procedimientos para su preparación y su uso como medicamentos | |
DK1728508T3 (da) | Farmaceutisk produkt til forebyggelse eller behandling af hyppig vandladning eller inkontinens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |